VYNE Therapeutics
VYNE
VYNE
36 hedge funds and large institutions have $1.33M invested in VYNE Therapeutics in 2025 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
90% less capital invested
Capital invested by funds: $13.4M → $1.33M (-$12M)
Holders
36
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$285K | |
| 2 | +$165K | |
| 3 | +$141K | |
| 4 |
Two Sigma Investments
New York
|
+$74K |
| 5 |
Two Sigma Advisers
New York
|
+$19K |
Top Sellers
| 1 | -$2.26M | |
| 2 | -$1.72M | |
| 3 | -$1.06M | |
| 4 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$1.05M |
| 5 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
-$942K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Renaissance Technologies
New York
| – |
|
|||
52
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
| – |
|